Invention Grant
- Patent Title: Method for improving the efficacy of a survivin vaccine in the treatment of cancer
-
Application No.: US14778897Application Date: 2013-03-27
-
Publication No.: US10022441B2Publication Date: 2018-07-17
- Inventor: Marc Mansour , Neil L. Berinstein , Genevieve Mary Weir , Marianne M. Stanford
- Applicant: IMMUNOVACCINE TECHNOLOGIES, INC.
- Applicant Address: CA Halifax, Nova Scotia
- Assignee: Immunovaccine Technologies, Inc.
- Current Assignee: Immunovaccine Technologies, Inc.
- Current Assignee Address: CA Halifax, Nova Scotia
- Agency: Troutman Sanders LLP
- International Application: PCT/CA2013/050248 WO 20130327
- International Announcement: WO2014/153636 WO 20141002
- Main IPC: A61K39/39
- IPC: A61K39/39 ; A61K31/675 ; A61K39/00 ; A61K9/127 ; A61K39/05
Abstract:
The present invention provides methods for improving the efficacy of a vaccine in the treatment of cancer. The methods of the invention comprise the administration of at least two doses of an agent that interferes with DNA replication prior to vaccination with a survivin vaccine. Also provided are compositions for use in the methods of the invention.
Public/Granted literature
- US20160067335A1 METHOD FOR IMPROVING THE EFFICACY OF A SURVIVIN VACCINE IN THE TREATMENT OF CANCER Public/Granted day:2016-03-10
Information query
